Salix Pharmaceuticals has appointed William Keane, chief financial officer and corporate secretary for Genta Inc., to its board of directors.
Previously, Keane held positions with Bristol-Myers Squibb, Covance Biotechnology Services, Warner-Lambert, Novartis and Ciba-Geigy. He received his MBA from Rutgers University School of Management.
“We are very pleased to welcome Bill to the Salix Board,” commented Salix Chairman John Chappell. “Bill’s industry background, financial expertise, and managerial and strategic experience provide a strong skill set that equip him to provide guidance and oversight to our growing operations.”